S. 3267ASAP Act
Progress: Introduction / referral onlyLatest action: Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S8278-8279)
119th CongressPolicy area: Health
- Bill CassidyCosponsorSep 28, 2026
- John KennedyCosponsorJan 12, 2026
Official CRS summary
Official CRS summary (Introduced in Senate version) · Congress.gov(opens in a new tab)
This bill provides for Medicare coverage of blood tests to screen for the early stages of Alzheimer’s disease or related dementias. Specifically, the bill provides for coverage of genomic sequencing blood or blood product tests, or other equivalent tests, that are approved by the Food and Drug Administration.